Boston Scientific (BSX) revenue

Revenue · fiscal 2025
$20.07B

Boston Scientific (BSX) reported revenue of $20.07B in fiscal 2025 (the year ended December 31, 2025). That is 19.9% higher than the $16.75B of fiscal 2024. Figures as of 18 Nov 2026, 09:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$20.07B
Change on fiscal 2024
+19.9%
Growth, 5 years
+15.2% a year
Growth, 10 years
+9.5% a year
Highest on record
$20.07Bfiscal 2025
Lowest on record
$6.96Bfiscal 2012
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Boston Scientific revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 15.2% a year; over ten years the rate was 9.5% a year. Across the 19 fiscal years on record (2007–2025), the highest was $20.07B in fiscal 2025 and the lowest $6.96B in fiscal 2012.

History · 19 fiscal years

Revenue by fiscal year

Boston Scientific revenue, year by year

Boston Scientific (BSX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$20.07B 19.9% up
2024$16.75B 17.6% up
2023$14.24B 12.3% up
2022$12.68B 6.7% up
2021$11.89B 19.9% up
2020$9.91B 7.7% down
2019$10.74B 9.3% up
2018$9.82B 8.6% up
2017$9.05B 7.9% up
2016$8.39B 3.9% up
2015$8.07B 8.1% up
2014$7.46B 5.5% up
2013$7.07B 1.6% up
2012$6.96B 8.7% down
2011$7.62B 2.4% down
2010$7.81B 4.7% down
2009$8.19B 1.7% up
2008$8.05B 3.7% down
2007$8.36B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Boston Scientific and comparable companies
CompanyRevenueFiscal year
Takeda Pharmaceutical TAK¥4.51T2026
Cencora COR$321.33B2025
Boston Scientific BSX$20.07B2025
Cardinal Health CAH$254.25B2026
argenx ARGX$4.15B2025
Edwards Lifesciences EW$6.07B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BSX

Boston Scientific, figure by figure

Boston Scientific (BSX) overview: price, valuation and scorecardAll health care companies by market value

Boston Scientific revenue: questions and answers

What is Boston Scientific's revenue?

Boston Scientific (BSX) reported revenue of $20.07B in fiscal 2025 (the year ended December 31, 2025). That is 19.9% higher than the $16.75B of fiscal 2024.

What is the growth rate of Boston Scientific's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 15.2% a year; over ten years the rate was 9.5% a year.

What are the highest and lowest revenue figures on record for Boston Scientific?

Across the 19 fiscal years on record (2007–2025), the highest was $20.07B in fiscal 2025 and the lowest $6.96B in fiscal 2012.

How is Boston Scientific's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Boston Scientific it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Boston Scientific (BSX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/BSX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.